The National Institute of Child Health and Human Development (NICHD) awarded a $2,283,054 Project Grant under CFDA 93.865, the Child Health and Human Development Extramural Research program, to CX Therapeutics, Inc. The grant aims to advance a novel medical device for treating cervical insufficiency, a pregnancy complication that can lead to preterm birth. Through this Phase II award, CX Therapeutics will finalize the device design, complete engineering verification, validate the device's performance on ex vivo tissue, assess biocompatibility, and conduct a limited first-in-human study. The project activities are intended to position the company for a future Phase IIb clinical trial and FDA clearance of the CX device, which is designed to improve upon current surgical cerclage treatments for cervical insufficiency and reduce adverse effects.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $0 | 11/15/24 | ||
| Not listed | $1.1m | 9/17/24 | ||
| Not listed | $1.1m | 9/17/24 |